The effect of proteoglycans inhibited by RNA interference on metastatic characters of human salivary adenoid cystic carcinoma

BMC Cancer

Volumn 9, Issue , 2009, Pages

  Shi, Hong ^a   Wang, Jie ^a   Dong, Fusheng ^a   Wang, Xu ^a   Li, Hexiang ^a   Hou, Yali ^a  

^a HEBEI MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

MESSENGER RNA; PROTEOGLYCAN; SHORT HAIRPIN RNA; TRANSFERASE; UNCLASSIFIED DRUG; XYLOSYLTRANSFERASE; ANTINEOPLASTIC AGENT; GLYCOSYLTRANSFERASE; SMALL INTERFERING RNA; UDP XYLOSE PROTEIN XYLOSYLTRANSFERASE; UDP XYLOSE-PROTEIN XYLOSYLTRANSFERASE;

ADENOID CYSTIC CARCINOMA; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER CELL CULTURE; CANCER INHIBITION; CANCER INVASION; CATALYSIS; CELL ADHESION; CELL INVASION; CELL STRAIN 3T3; CONTROLLED STUDY; DOWN REGULATION; EXPRESSION VECTOR; FEMALE; GENE EXPRESSION REGULATION; GENE SILENCING; GENE TARGETING; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; LUNG METASTASIS; METASTASIS POTENTIAL; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; NUDE MOUSE; PLASMID; PROTEIN EXPRESSION; PROTEIN SECRETION; PROTEIN SYNTHESIS INHIBITION; PROTEOGLYCAN SYNTHESIS; REAL TIME POLYMERASE CHAIN REACTION; RNA INTERFERENCE; SALIVARY GLAND CARCINOMA; WESTERN BLOTTING; ANIMAL; BAGG ALBINO MOUSE; DRUG ANTAGONISM; DRUG EFFECT; DRUG SCREENING; GENETICS; METASTASIS; PATHOLOGY; PHYSIOLOGY; SALIVARY GLAND TUMOR; TUMOR CELL CULTURE;

ANIMALS; ANTINEOPLASTIC AGENTS; BASE SEQUENCE; CARCINOMA, ADENOID CYSTIC; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE KNOCKDOWN TECHNIQUES; GENE TARGETING; HUMANS; MICE; MICE, INBRED BALB C; MICE, NUDE; NEOPLASM METASTASIS; NIH 3T3 CELLS; PENTOSYLTRANSFERASES; PROTEOGLYCANS; RNA INTERFERENCE; RNA, SMALL INTERFERING; SALIVARY GLAND NEOPLASMS; TUMOR CELLS, CULTURED; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 74549185676     PISSN: None     EISSN: 14712407     Source Type: Journal    
DOI: 10.1186/1471-2407-9-456     Document Type: Article

References (56)

1. Iozzo RV. Matrix proteoglycans: from molecular design to cellular function. Annu Rev Biochem 1998, 67:609-652. 10.1146/annurev.biochem.67.1.609, 9759499.
2. Kjellen L, Lindahl U. Proteoglycans: structures and interactions. Annu Rev Biochem 1991, 60:443-475. 10.1146/annurev.bi.60.070191.002303, 1883201.
3. Mulloy B, Forster MJ. Conformation and dynamics of heparin and heparan sulfate. Glycobiology 2000, 10:1147-1156. 10.1093/glycob/10.11.1147, 11087707.
4. Kazuyuki S, Hiroshi K. Heparin and Heparan sulfate Biosynthesis. IUBMB Life 2002, 54:163-175. 10.1080/15216540214928, 12512855.
5. Bame KJ, Venkatesan I, Stelling HD, Tumova S. The spacing of S-domains on HS glycosaminoglycans determines whether the chain is a substrate for intracellular heparanases. Glycobiology 2000, 10:715-726. 10.1093/glycob/10.7.715, 10910975.
6. Muller S, Schottler M, Schon S, Prante C, Brinkmann T, Kuhn J, Gotting C, Kleesiek K. Human xylosyltransferase I: functional and biochemical-characterization of cysteine residues required for enzymicactivity. Biochem J 2005, 386(Pt 2):227-236. 1134786, 15461586.
7. Gotting C, Kuhn J, Zahn R, Brinkmann T, Kleesiek K. Molecular cloning and expression of human UDP-D-Xylose: Proteoglycan Core Protein β-D- Xylosyltransferase and its first isoform XT-II. J Mol Biol 2000, 304:517-528. 10.1006/jmbi.2000.4261, 11099377.
8. Kuhn J, Prante C, Schon S, Gotting C, Kleesiek K. Measurement of fibrosis marker xylosyltransferase I activity by HPLC electrospray ionization tandem mass spectrometry. Clin Chem 2006, 52:2243-2249. 10.1373/clinchem.2006.071167, 17040958.
9. Gotting C, Hendig D, Adam A, Schon S, Schulz V, Szliska C, Kuhn J, Kleesiek K. Elevated xylosyltransferase I activities in pseudoxanthoma elasticum (PXE) patients as a marker of stimulated proteoglycan biosynthesis. J Mol Med 2005, 83:984-992. 10.1007/s00109-005-0693-x, 16133423.
10. Gotting C, Kuhn J, Sollberg S, Huerkamp C, Brinkmann T, Krieg T, Kleesiek K. Elevated serum xylosyltransferase activity correlated with a high level of hyaluronate in patients with systemic sclerosis. Acta Derm Venereol 2000, 80:60-61. 10.1080/000155500750012612, 10721843.
11. Bradley PJ. Adenoid cystic carcinoma of the head and neck: a review. Curr Opin Otolaryngol Head Neck Surg 2004, 12:127-132. 10.1097/00020840-200404000-00013, 15167050.
12. Spiro RH. Distant metastasis in adenoid cystic carcinoma of salivary origin. Am J Surg 1997, 174:495-498. 10.1016/S0002-9610(97)00153-0, 9374223.
13. William H, Westra MD. The surgical pathology of salivary gland neoplasms. Otolaryngol Clin North Am 1999, 32:919-943. 10.1016/S0030-6665(05)70182-1, 10477796.
14. Jie W, Qiguang W, Kai-hua S. The relationship between the secretion of proteoglycan and the histological types of salivary adenoid cystic carcinoma. Zhonghua Yixue Zazhi 1994, 74:434-435. Article in Chinese.
15. Nakanishi K, Kawai T, Suzuki M, Shinmei M. Glycosaminoglycans in pleomorphic adenoma and adenoid cystic carcinoma of the salivary gland. Arch Pathol Lab Med 1990, 114:1227-1231.
16. Allon I, Vered M, Buchner A, Dayan D. Stromal differences in salivary gland tumors of a common histopathogenesis but with different biological behavior: A study with picrosirius red and polarizing microscopy. Acta Histochemca 2006, 108:259-264.
17. Pappas TC, Bader AG, Andruss BF, Brown D, Ford PL. Applying small RNA molecules to the directed treatment of human diseases: realizing the potential Expert Opin. Ther Targets 2008, 12:115-127.
18. Shi H, Jie W, Fusheng D, Xu W, Hongtao G, Lijie Y. Preparation and identification of anti-human polyclonal antibody against xylosyltransferase-I. Xibao Yu Fenzi Mianyixue 2007, 23:1028-1030. 1040. Article in Chinese.
19. Tuschl T. Expanding small RNA interference. Nat Biotechnol 2002, 20:446-448. 10.1038/nbt0502-446, 11981553.
20. Brummelkamp TR, Bernards R, Agami R. A System for Stable Expression of Short Interfering RNAs in Mammalian Cells. Science 2002, 550-553. Article in Chinese, 10.1126/science.1068999, 11910072.
21. Shi H, Jie W, Xu W, Yali H. Construction of Eukaryotic Expression Vector of Short Hairpin RNA against Human Xylosyltransferase-I Gene. Huaxi Kouqiang Yixue Zazhi 2008, 11:206-210. Article in Chinese.
22. Higuchi R, Fockler C, Dollinger G, Watson R. Kinectic PCR: Real-time monitoring of DNA amplification reactions. Biotechnology 1993, 11:1026-1030. 10.1038/nbt0993-1026, 7764001.
23. Yoneno K, Ohno S, Tanimoto K, Honda K, Tanaka N, Doi T, Kawata T, Tanaka E, Kapila S, Tanne K. Multidifferentiation potential of mesenchymal stem cells in three-dimensional collagen gel cultures. J Biomed Mater Res 2005, 75:733-741.
24. French MM, Rose S, Canesco J, Athanasiou KA. Chondrogenic differentiation of adult dermal fibroblasts: musculoskeketal engineering. Ann Biomed Engineer 2004, 32:50-56.
25. Schon S, Prane C, Bahr C, Knut J, Kleesiek K, Gotting C. Cloning and recombinant expression of active full-length xylosyltransferase I (XT-I) and characterization of subcellular localization of XT-I and XT-II. J Biol Chem 2006, 281:14224-14231. 10.1074/jbc.M510690200, 16569644.
26. Wilson IB. The never-ending story of peptide O-xylosyltransferase. Cell Mol Life Sci 2004, 61(7-8):794-809. 10.1007/s00018-003-3278-2, 15095004.
27. Wang J, Qiguang W, Kai-hua S. An electron microscopic histochemical study on proteoglycans in salivary gland myoepithelioma. Zhonghua Kouqiang Yixue Zazhi 1995, 30(4):215. Article in Chinese.
28. Kimura S, Cheng J, Ida H, Hao N, Fujimori Y, Saku T. Perlecan (heparan sulphate proteoglycan) gene expression reflected in the characteristic histological architecture of salivary adenoid cystic carcinoma. Virchows Arch 1999, 437:122-128.
29. Kimura S, Cheng J, Toyoshima K, Oda K, Saku T. Basement membrane heparan sulfate proteoglycan (perlecan) synthesized by ACC3, adenoid cystic carcinoma cells of human salivary gland origin. J Biochem 1999, 125:406-413.
30. Paddison PJ, Caudy AA, Bernstein E, Hannon GJ, Conklin DS. Short-hairpin RNAs (shRNAs) induce sequence- specific silencing in mammalian cells. Genes & Dev 2002, 16:948-958. 152352, 11959843, 10.1101/gad.981002.
31. Paddison PJ, Caudy AA, Hannon GJ. Stable suppression of gene expression by RNAi in mammalian cells. Proc Natl Acad Sci USA 2002, 99:1443-1448. 10.1073/pnas.032652399, 122210, 11818553.
32. Soutschek J, Akinc A, Bramlage B, Charisse K, Constien R, Donoghue M, Elbashir S, Geick A, Hadiwger P, Harborth J, John M, Kesavan V, Lavine G, Pandey RK, Racie T, Rajeev KG, Rohl I, Toudjarska I, Wang G, Wuschko S, Bumcrot D, Koteliansky V, Limmer S, Manoharan M, Vornlocher H. Therapeutic silencing of an endogenous gene by systemic administration of modified siRNAs. Nature 2004, 432:173-178. 10.1038/nature03121, 15538359.
33. Muller S, Disse J, Schotter M, Schon S, Prante C, Brinkmann T, Kuhn J, Kleesiek K, Gotting C. Human xylosyltransferase I and N-terminal truncated forms: functional characterization of the core enzyme. Biochem J 2006, 394(Pt 1):163-171. 1386014, 16225459.
34. Kusafuka K, Ishiwata T, Sugisaki Y, Takemura T, Kusafuka M, Hisha H, Ikehara S. Lumican expression is associated with the formation of mesenchyme-like elements in salivary pleomorphic adenomas. J Pathol 2004, 203:953-960. 10.1002/path.1599, 15258999.
35. Zhao M, Takata T, Ogawa I, Toshika K, Koli K, Hiromasa N. Immunohistochemical evaluation of the small and large proteoglycans in pleomorphic adenoma of salivary glands. J Oral Pathol Med 1999, 28:37-42.
36. Munakata R, Irie T, Cheng J, Nakajima T, Saku T. Pseudocyst formation by adenoid cystic carcinoma cells in collagen gel culture and in SCID mice. J Oral Pathol Med 1996, 25:441-448. 10.1111/j.1600-0714.1996.tb00294.x, 8930823.
37. Barsky SH. Myoepithelial mRNA expression profiling reveals a common tumor-suppressor phenotype. Exp Mol Pathl 2003, 74:113-122.
38. Sternlicht MD, Safarians S, Rivera SP, Barsky SH. Characterizations of the extracellular matrix and proteinase inhibitor content of human myoepithelial tumors. Lab Invest 1996, 74:781-796.
39. Jinxiong W, Jun C, Kaiyu R, Jin S, Yifang Z. Expression of HSPG and Fibronectin mRNA in Metastatic ACC Cell Line. Kouqiang Yixue Yangjiu 2004, 20:489-491. Article in Chinese.
40. Lance A, Liotta, William G, Stetler-Stevenson. Tumor invasion and metastasis: an imbalance of positive and negative regulation. Cancer Res 1991, 51(18 Suppl):5054-5059.
41. Nicolson GL. Organ specificity of tumor metastasis: role of preferential adhesion, invasion and growth of malignant cell at specific secondary sites. Cancer Metastasis Rev 1988, 7:143-88. Review, 10.1007/BF00046483, 3293836.
42. Cheng J, Irie T, Munakata R, Kimura S, Saku T, Nakamura H, He RG, Liu R. Biosynthesis of basement membrane molecules by salivary adenoid cystic carcinoma cells: an immunofluorescence and confocal microscopic study. Virchows Arch 1995, 426:7-586.
43. Ghiselli G, Eichstetter I, Iozzo RV. A role for the perlecan protein core in the activation of the keratinocyte growth factor receptor. Biochem J 2001, 359(Pt 1):153-163. 10.1042/0264-6021:3590153, 11563979, 1222131.
44. Iozzo RV, San Antonio JD. Heparan sulfate proteoglycans: heavy hitters in the angiogenesis arena. J Clin Invest 2001, 108:349-355. 209371, 11489925.
45. Sugahara K, Kitagawa H. Heparin and Heparan sulfate Biosynthesis. IUBMB Life 2002, 54:163-175. 10.1080/15216540214928, 12512855.
46. Bame KJ, Venkatesan I, Stelling HD, Tumova S. The spacing of S-domains on HS glycosaminoglycans determines whether the chain is a substrate for intracellular heparanases. Glycobiology 2000, 10:715-726. 10.1093/glycob/10.7.715, 10910975.
47. Hashimoto Y, Skacel M, Adams JC. Association of loss of epithelial syndecan-1 with stage and local metastasis of colorectal adenocarcinomas: an immunohistochemical study of clinically annotated tumors. BMC Cancer 2008, 30:185.
48. Hara S, Nakashiro K, Goda H, Hamakawa H. Role of Akt isoforms in HGF-induced invasive growth of human salivary gland cancer cells. Biochem Biophys Res Commun 2008, 370:123-128. 10.1016/j.bbrc.2008.03.042, 18355439.
49. Morais Freitas V, Nogueira da Gama de Souza L, Cyreno Oliveira E, Furuse C, Cavalcanti de Araújo V, Gastaldoni Jaeger R, . Malignancy-related, 67KD laminin receptor in adenoid cystic carcinoma Effect on migration and β-catenin expression. Oral Oncology 2007, 43:987-998. 10.1016/j.oraloncology.2006.11.005, 17257887, Malignancy-related, 67KD laminin receptor in adenoid cystic carcinoma.
50. Ghiselli G, Eichstetter I, Iozzo RV. A role for the perlecan protein core in the activation of the keratinocyte growth factor receptor. Biochem J 2001, 359(Pt 1):153-163. 10.1042/0264-6021:3590153, 1222131, 11563979.
51. Tapanadechopone P, Tumova S, Jiang X, Couchman JR. Epidermal transformation leads to increased perlecan synthesis with heparin-binding-growth-factor affinity. Biochem J 2001, 355(Pt 2):517-527. 10.1042/0264-6021:3550517, 1221765, 11284741.
52. Timar J, Ladanyi A, Lapis K, Moczar M. Differential expression of proteoglycans on the surface of human melanoma cells characterized by altered experimental metastatic potential. Am J Pathol 1992, 141:467-474. 1886594, 1379782.
53. Sternlicht MD, Safayians S, Rivera SP, Barsky S. Characterizations of the extracellular matrix and proteinase inhibitor content of human myoepithelial tumors. Lab Invest 1996, 74:781-796.
54. Jie W, Qiguang W, Kaihua S, Chengrui B. Quantitative multivariate analysis of myoepithelioma and myoepithelial carcinoma. Int J Oral Maxillofac Surg 1995, 24:153-157. 10.1016/S0901-5027(06)80091-3, 7608581.
55. Franca CM, Jaeger MM, Jaeger RG, Araujo NS. The role of basement membrane proteins on the expression of neural cell adhesion molecule (N-CAM) in an adenoid cystic carcinoma cell line. Oral Oncol 2000, 36:248-252. 10.1016/S1368-8375(99)00087-1, 10745180.
56. Dhodapkar MV, Abe E, Theus A, Lacy M, Langford JK, Barlogie B, Sanderson RD. Syndecan-1 is a multifunctional regulator of myeloma pathobiology: Control of tumor cell survival, growth, and bone cell differentiation. Blood 1998, 91:2679-2688.